We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+23.56%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$135M
AUM Growth
+$62.2M
Cap. Flow
+$48.4M
Cap. Flow %
35.91%
Top 10 Hldgs %
44.79%
Holding
162
New
9
Increased
113
Reduced
25
Closed
15

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$4.79M
2
EEP
Enbridge Energy Partners
EEP
+$3.1M
3
PAA icon
Plains All American Pipeline
PAA
+$2.86M
4
WPZ
Williams Partners L.P.
WPZ
+$2.84M
5
ETP
Energy Transfer Partners, L.P.
ETP
+$2.77M

Top Sells

Rank Stock Value
1
TRGP icon
Targa Resources
TRGP
+$572K
2
XNPT
XENOPORT, INC.
XNPT
+$458K
3
MDVN
MEDIVATION, INC.
MDVN
+$291K
4
TBPH icon
Theravance Biopharma
TBPH
+$289K
5
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$275K

Sector Composition

Rank Sector Weight
1 Energy 64.17%
2 Healthcare 25.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLYP
51
DELISTED
RELYPSA INC COM
RLYP
$521K 0.39%
28,163
+18,936
+205% +$332K
MNTA
52
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$520K 0.39%
48,151
+10,869
+29% +$112K
REGN icon
53
Regeneron Pharmaceuticals
REGN
$68.3B
$519K 0.39%
1,485
+428
+40% +$165K
ENTA icon
54
Enanta Pharmaceuticals
ENTA
$377M
$514K 0.38%
23,292
+4,603
+25% +$120K
NKTR icon
55
Nektar Therapeutics
NKTR
$2.34B
$514K 0.38%
2,410
-141
-6% -$31.5K
OMER icon
56
Omeros
OMER
$744M
$514K 0.38%
48,887
+4,650
+11% +$57.2K
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$120B
$512K 0.38%
5,955
+922
+18% +$79.7K
MDCO
58
DELISTED
Medicines Co
MDCO
$502K 0.37%
14,919
-412
-3% -$14.5K
PGNX
59
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$499K 0.37%
118,285
+14,478
+14% +$69.9K
ARIA
60
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$489K 0.36%
66,113
-26,489
-29% -$199K
ALXN
61
DELISTED
Alexion Pharmaceuticals
ALXN
$484K 0.36%
4,147
+980
+31% +$139K
ARNA
62
DELISTED
Arena Pharmaceuticals Inc
ARNA
$475K 0.35%
27,761
-4,550
-14% -$81.3K
MACK
63
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$472K 0.35%
11,118
+7,105
+177% +$387K
ACAD icon
64
Acadia Pharmaceuticals
ACAD
$4.25B
$450K 0.33%
13,877
+6,520
+89% +$218K
CQP icon
65
Cheniere Energy
CQP
$31.9B
$350K 0.26%
+11,685
New +$341K
XNCR icon
66
Xencor
XNCR
$1.45B
$335K 0.25%
17,649
-391
-2% -$5.36K
ATRA icon
67
Atara Biotherapeutics
ATRA
$73.6M
$285K 0.21%
506
+49
+11% +$23.5K
CYTK icon
68
Cytokinetics
CYTK
$11.1B
$279K 0.21%
29,379
+7,255
+33% +$59.5K
LUMO
69
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$275K 0.2%
2,718
+1,937
+248% +$240K
NVAX icon
70
Novavax
NVAX
$1.29B
$273K 0.2%
1,878
+339
+22% +$38.9K
ONCE
71
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$270K 0.2%
5,281
+30
+0.6% +$1.28K
BLUE
72
DELISTED
bluebird bio
BLUE
$267K 0.2%
476
+148
+45% +$83.8K
ARRY
73
DELISTED
Array Biopharma Inc
ARRY
$267K 0.2%
75,100
+8,724
+13% +$28.4K
IOVA icon
74
Iovance Biotherapeutics
IOVA
$2.29B
$265K 0.2%
32,726
+374
+1% +$2.35K
BPMC
75
DELISTED
Blueprint Medicines
BPMC
$264K 0.2%
13,046
+2,562
+24% +$46.6K
1 2
3
4 5

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
OC
Optima Capital Beaverton, Oregon $215M AUM 17.28% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Virtus ETF Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, Virtus ETF Advisers held 162 positions worth $135M, up 86% from $72.6M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Virtus ETF Advisers deployed $48.4M of net new capital in Q2 2016, opening 9 new positions and adding to 113 existing holdings. Its largest new stake was Cheniere Energy: 11,685 shares worth $350K.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 49% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Targa Resources, an estimated $572K trimmed.

  • Virtus ETF Advisers's largest Q2 2016 buy was Cheniere Energy: 11,685 shares worth $350K.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q2 2016, an estimated $4.79M increase.
  • Virtus ETF Advisers's biggest Q2 2016 reduction was Targa Resources, cutting an estimated $572K.
  • Virtus ETF Advisers fully exited XENOPORT, INC. in Q2 2016, selling an estimated $458K.
  • Virtus ETF Advisers's ten largest holdings make up 45% of its $135M portfolio in Q2 2016.
  • Virtus ETF Advisers opened 9 new positions and closed 15 in Q2 2016.
  • Virtus ETF Advisers's portfolio value rose 86% quarter-over-quarter to $135M.

Based on Virtus ETF Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.